Baird Financial Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-54,615	Closed	-$560K	–	1349
2018 Q4	$560K	Buy	54,615 +3,840	+8%	+$49.2K	﹤0.01%	953
2018 Q3	$755K	Buy	50,775 +1,021	+2%	+$18.5K	﹤0.01%	925
2018 Q2	$786K	Buy	49,754 +403	+0.8%	+$6.12K	0.01%	885
2018 Q1	$627K	Sell	49,351 -9,989	-17%	-$144K	﹤0.01%	950
2017 Q4	$679K	Sell	59,340 -12,592	-18%	-$141K	﹤0.01%	925
2017 Q3	$881K	Buy	71,932 +43,996	+157%	+$459K	0.01%	834
2017 Q2	$320K	Buy	27,936 +9,495	+51%	+$176K	﹤0.01%	1070
2017 Q1	$384K	Buy	18,441 +1,349	+8%	+$29.9K	﹤0.01%	1016
2016 Q4	$356K	Buy	17,092 +1,841	+12%	+$47.9K	﹤0.01%	1013
2016 Q3	$500K	Sell	15,251 -479	-3%	-$14.6K	﹤0.01%	937
2016 Q2	$402K	Buy	+15,730	New	+$426K	﹤0.01%	969